250 related articles for article (PubMed ID: 34638959)
21. Dauricine upregulates the chemosensitivity of hepatocellular carcinoma cells: Role of repressing glycolysis via miR-199a:HK2/PKM2 modulation.
Li W; Qiu Y; Hao J; Zhao C; Deng X; Shu G
Food Chem Toxicol; 2018 Nov; 121():156-165. PubMed ID: 30171973
[TBL] [Abstract][Full Text] [Related]
22. Metformin induces G1 cell cycle arrest and inhibits cell proliferation in nasopharyngeal carcinoma cells.
Zhao L; Wen ZH; Jia CH; Li M; Luo SQ; Bai XC
Anat Rec (Hoboken); 2011 Aug; 294(8):1337-43. PubMed ID: 21717584
[TBL] [Abstract][Full Text] [Related]
23. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
Liu Y; Zhao Y; Guo L
Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
[TBL] [Abstract][Full Text] [Related]
24. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
Li C; Liu VW; Chan DW; Yao KM; Ngan HY
Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
[TBL] [Abstract][Full Text] [Related]
25. Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: a crucial role of AMPK and mTOR pathways.
Chiang PC; Lin SC; Pan SL; Kuo CH; Tsai IL; Kuo MT; Wen WC; Chen P; Guh JH
Biochem Pharmacol; 2010 Jan; 79(2):162-71. PubMed ID: 19723512
[TBL] [Abstract][Full Text] [Related]
26. Induction of cytoprotective autophagy by morusin via AMP-activated protein kinase activation in human non-small cell lung cancer cells.
Park HJ; Park SH
Nutr Res Pract; 2020 Oct; 14(5):478-489. PubMed ID: 33029288
[TBL] [Abstract][Full Text] [Related]
27. Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition.
Charette N; De Saeger C; Lannoy V; Horsmans Y; Leclercq I; Stärkel P
Mol Cancer; 2010 Sep; 9():256. PubMed ID: 20860815
[TBL] [Abstract][Full Text] [Related]
28. β-Cryptoxanthin induced anti-proliferation and apoptosis by G0/G1 arrest and AMPK signal inactivation in gastric cancer.
Gao M; Dang F; Deng C
Eur J Pharmacol; 2019 Sep; 859():172528. PubMed ID: 31288004
[TBL] [Abstract][Full Text] [Related]
29. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
30. Autophagy and glycolysis independently attenuate silibinin-induced apoptosis in human hepatocarcinoma HepG2 and Hep3B cells.
Yang J; Sun Y; Xu F; Liu W; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Ikejima T
Hum Exp Toxicol; 2021 Dec; 40(12):2048-2062. PubMed ID: 34053323
[TBL] [Abstract][Full Text] [Related]
31. Sauchinone exerts anticancer effects by targeting AMPK signaling in hepatocellular carcinoma cells.
Kim YW; Jang EJ; Kim CH; Lee JH
Chem Biol Interact; 2017 Jan; 261():108-117. PubMed ID: 27871897
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of GSK-3β activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK/mTOR signaling.
Fang G; Zhang P; Liu J; Zhang X; Zhu X; Li R; Wang H
Cancer Lett; 2019 Oct; 463():11-26. PubMed ID: 31404613
[TBL] [Abstract][Full Text] [Related]
33. Sinensetin Induces Autophagic Cell Death through p53-Related AMPK/mTOR Signaling in Hepatocellular Carcinoma HepG2 Cells.
Kim SM; Ha SE; Lee HJ; Rampogu S; Vetrivel P; Kim HH; Venkatarame Gowda Saralamma V; Lee KW; Kim GS
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32824273
[TBL] [Abstract][Full Text] [Related]
34. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
[TBL] [Abstract][Full Text] [Related]
35. Preparation of morusin from Ramulus mori and its effects on mice with transplanted H22 hepatocarcinoma.
Wan LZ; Ma B; Zhang YQ
Biofactors; 2014; 40(6):636-45. PubMed ID: 25422054
[TBL] [Abstract][Full Text] [Related]
36. The mTOR Pathway Regulates PKM2 to Affect Glycolysis in Esophageal Squamous Cell Carcinoma.
Xiaoyu H; Yiru Y; Shuisheng S; Keyan C; Zixing Y; Shanglin C; Yuan W; Dongming C; Wangliang Z; Xudong B; Jie M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818780063. PubMed ID: 29916308
[TBL] [Abstract][Full Text] [Related]
37. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
Zhou Q; Lui VW; Lau CP; Cheng SH; Ng MH; Cai Y; Chan SL; Yeo W
Biochem Pharmacol; 2012 May; 83(9):1146-58. PubMed ID: 22285225
[TBL] [Abstract][Full Text] [Related]
38. Mechanistic Action of Cell Cycle Arrest and Intrinsic Apoptosis via Inhibiting Akt/mTOR and Activation of p38-MAPK Signaling Pathways in Hep3B Liver Cancer Cells by Prunetrin-A Flavonoid with Therapeutic Potential.
Abusaliya A; Jeong SH; Bhosale PB; Kim HH; Park MY; Kim E; Won CK; Park KI; Heo JD; Kim HW; Ahn M; Seong JK; Kim GS
Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571343
[TBL] [Abstract][Full Text] [Related]
39. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.
Singh AR; Joshi S; Burgoyne AM; Sicklick JK; Ikeda S; Kono Y; Garlich JR; Morales GA; Durden DL
Mol Cancer Ther; 2016 Nov; 15(11):2553-2562. PubMed ID: 27496136
[TBL] [Abstract][Full Text] [Related]
40. 1-(2-Hydroxy-5-methylphenyl)-3-phenyl-1,3-propanedione Induces G1 Cell Cycle Arrest and Autophagy in HeLa Cervical Cancer Cells.
Tsai JH; Hsu LS; Huang HC; Lin CL; Pan MH; Hong HM; Chen WJ
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27527160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
